Last $161.56 USD
Change Today +0.03 / 0.02%
Volume 674.1K
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ruedi E. Waeger Ph.D.

Former Independent Director, Chairman of Compliance & Quality Committee and Member of Compensation Committee, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 2 different organizations across 2 different industries.

See Board Relationships
71--

Background*

Dr. Ruedi E. Waeger, Ph.D. served is the President and Chief Executive Officer of Aventis Behring L.L.C. Mr. Waeger served as President and Chief Executive Officer of ZLB Central Laboratory, Blood Transfusion Service for the Swiss Red Cross. He serves as Chairman of PharmaServ GmbH & Co. Mr. Waeger has been a Director of Eximias Pharmaceutical Corporation since June 6, 2005. Mr. Waeger is a Director of Talecris Biotherapeutics Holdings Corp. since April 2005 and YM BioSciences ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

Director
2005-Present
Director
2005-2010
Former Independent Director, Chairman of Compliance & Quality Committee and Member of Compensation Committee
2005-2011
Former Director, Chairman of Compliance & Quality Committee and Member of Nominating & Governance Committee

Education*

PhD
Eidgenössische Technische Hochschule Zürich

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $161.56 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jay T. Flatley Chief Executive Officer and Director
Illumina Inc.
$1.1M
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Managing Director, Chief Executive Officer, Member of The Management Council, Member of Management Committee, Member of Investment Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders' Relationship Committee
Dr. Reddy's Laboratories Ltd.
6.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.